Literatur
Venook AP, Niedzwiecki D, Lenz H et al (2017) Effect of First-Line Chemotherapy Combined With Cetuximab or Bevacizumab on Overall Survival in Patients With KRAS Wild-Type Advanced or Metastatic Colorectal Cancer: A Randomized Clinical Trial. JAMA 317(23):2392–2401. https://doi.org/10.1001/jama.2017.7105
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Interessenkonflikt
F. Kütting, M. Bludau, H. Alakus und C. Bruns geben an, dass kein Interessenkonflikt besteht.
Rights and permissions
About this article
Cite this article
Kütting, F., Bludau, M., Alakus, H. et al. MSI und Tumormutationslast beim kolorektalen Karzinom. Onkologe 25, 829–830 (2019). https://doi.org/10.1007/s00761-019-0611-4
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00761-019-0611-4